Nader Rifai

发表

Identifying duplicate publications: primum non nocere.

Patrick M Bossuyt, David E Bruns, Nader Rifai, 2008, Clinical chemistry.

AACC Learning Lab for Laboratory Medicine on NEJM Knowledge+: Clinical Chemistry Recognizes the Contributors.

Nader Rifai, 2018, Clinical chemistry.

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

Steven A Carr, Nader Rifai, Michael A Gillette, 2006, Nature Biotechnology.

STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies

David Moher, Johannes B Reitsma, Lotty Hooft, 2015, BMJ : British Medical Journal.

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

Nancy R Cook, Nader Rifai, Paul M Ridker, 2002, The New England journal of medicine.

Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial

Amy Shui, Nader Rifai, Robert M Califf, 2006, Circulation.

Commercial immunoassays in biomarkers studies: researchers beware!

W Greg Miller, Nader Rifai, Ian D Watson, 2012, Clinical chemistry.

Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment.

Nader Rifai, N. Rifai, T. Ledue, 2003, Clinical chemistry.

Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

Nader Rifai, Christopher P Cannon, David A Morrow, 2008, European heart journal.

Common Polymorphisms in the Adiponectin and Its Receptor Genes, Adiponectin Levels and the Risk of Prostate Cancer

Jing Ma, Meir J. Stampfer, Fredrick Schumacher, 2011, Cancer Epidemiology, Biomarkers & Prevention.

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

Paul M. Ridker, Nancy R. Cook, Nader Rifai, 2003 .

Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men.

Lu Qi, Nader Rifai, Frank B Hu, 2005, Diabetes care.

Inflammatory markers and risk of developing type 2 diabetes in women.

Nader Rifai, JoAnn E Manson, Frank B Hu, 2004, Diabetes.

Practice Guidelines : Emerging Biomarkers for Primary Prevention of Cardiovascular Disease

Mary Cushman, Gary L Myers, Nader Rifai, 2009 .

Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death

Paul M. Ridker, Meir J. Stampfer, Jing Ma, 2002, Circulation.

Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.

Nader Rifai, Frank B Hu, Meir J Stampfer, 2004, Diabetes care.

Non–High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men

Nader Rifai, Meir J Stampfer, E. Rimm, 2005, Circulation.

Inflammation, Statin Therapy, and Risk of Stroke After an Acute Coronary Syndrome in the MIRACL Study

Nader Rifai, Michael Szarek, Peter Libby, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events

Samia Mora, Nader Rifai, Paul M Ridker, 2008, Circulation.

Plasma adiponectin levels and risk of myocardial infarction in men.

Nader Rifai, Frank B Hu, E. Rimm, 2004, JAMA.

Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women

Paul M. Ridker, Nancy R. Cook, Nader Rifai, 2007 .

Soluble Intercellular Adhesion Molecules, Soluble Vascular Cell Adhesion Molecules, and Risk of Coronary Heart Disease

Nader Rifai, Iris Shai, E. Rimm, 2006, Obesity.

Blood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events

Nader Rifai, Paul M Ridker, P. Ridker, 2003, Circulation.

Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk.

Nader Rifai, David F Dinges, Paul M Ridker, 2004, Journal of the American College of Cardiology.

Sex hormone-binding globulin and risk of type 2 diabetes in women and men.

David J Hunter, Nader Rifai, J Michael Gaziano, 2009, The New England journal of medicine.

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Paul M. Ridker, Nader Rifai, P. Ridker, 2001, The New England journal of medicine.

What is a biomarker? Research investments and lack of clinical integration necessitate a review of biomarker terminology and validation schema

Nader Rifai, Adam S Ptolemy, N. Rifai, 2010, Scandinavian journal of clinical and laboratory investigation. Supplementum.

Differential Expression of Cardiac Biomarkers by Gender in Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy–Thrombolysis In Myocardial Infarction 18) Substudy

Robert P. Giugliano, Nader Rifai, David A. Morrow, 2004, Circulation.

Inflammatory markers and the risk of coronary heart disease in men and women.

Jing Ma, Nader Rifai, Carolyn C Cannuscio, 2004, The New England journal of medicine.

Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide

Nader Rifai, Christopher P Cannon, David A Morrow, 2002, Circulation.

Association between dietary factors and plasma adiponectin concentrations in men.

Nader Rifai, E. Rimm, T. Pischon, 2005, The American journal of clinical nutrition.

Handbook of Lipoprotein Testing

Nader Rifai, Marek H. Dominiczak, G. Russell Warnick, 2001 .

Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.

Nader Rifai, Christopher P Cannon, David A Morrow, 2005, Journal of the American College of Cardiology.

Multiple Biomarkers and the Risk of Incident Hypertension

Nader Rifai, Daniel Levy, Ramachandran S Vasan, 2007, Hypertension.

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.

Paul M. Ridker, Meir J. Stampfer, Nader Rifai, 2001 .

Plasma adiponectin levels and risk of myocardial infarction in men.

Cynthia J. Girman, Nader Rifai, Frank B. Hu, 2004, JAMA.

Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation.

Nader Rifai, N. Rifai, G. Warnick, 2002, Clinical chemistry.

C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women

Nancy R Cook, Nader Rifai, Paul M Ridker, 2003, Circulation.

Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women

Samia Mora, Nader Rifai, Paul M Ridker, 2009, Circulation.

Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.

Joshua LaBaer, Ann L Oberg, Christopher R Kinsinger, 2013, Journal of proteome research.

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Gary L Myers, Nader Rifai, George A Mensah, 2003, Circulation.

Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction.

Nader Rifai, Walter C Willett, JoAnn E Manson, 2005, The Journal of nutrition.